• MicroPort unit Suzhou MicroPort signed a letter of intent with Tinavi for Tinavi to buy control of Shanghai MicroPort Orthopedics.
• The target is the core operating entity for MicroPort’s orthopedics business outside China, with hip and knee products sold in the US, Japan, Europe.
• Consideration would be paid through newly issued Tinavi shares, leaving MicroPort with equity exposure to the combined business.
• The parties are positioning the tie-up to pair Tinavi’s orthopedic surgical robotics with the target’s implant portfolio and global distribution network.
• The deal remains subject to due diligence, negotiations, definitive documentation, and internal and regulatory approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroPort Scientific Corporation published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein.